Artemis Bioservices (formerly known as Artemis Bio-Support)
Martin Schutten is the Chief Scientific Officer and founder of IQ-IDM, a biotech company focused on developing therapies for unmet medical needs by repurposing drugs with a known safety profile and clinical effect in men. He also holds the position of Chief Scientific Officer at Chimunomics LtD, where he provides consultancy services in human challenge trials and oversees the production process of new challenge agents. With a strong background in virology, Martin has experience in clinical research, trial design, diagnostic methods, and laboratory assessments. He has held various leadership roles in companies such as Clinical Virology and Diagnostics, Viroclinics Biosciences BV, and Erasmus MC, where he managed teams, developed diagnostic methods, and conducted research on HIV-1 vaccine development. Martin holds a Doctor of Philosophy (PhD) in Medical Microbiology from Erasmus University Rotterdam and a Master's degree in Medical Biology from the University of Amsterdam.
Artemis Bioservices (formerly known as Artemis Bio-Support)
Artemis Bioservices is a private, non-profit CRO specialized in vaccine and antiviral evaluation. Vision of Artemis Bioservices: The vision of Artemis Bioservices is to become a strategic partner in the process of antiviral, antibody and vaccine development against emerging viral diseases. Mission of Artemis Bioservices: To assist biotech and biopharmaceutical companies to accelerate the development and licensing of safe and effective antiviral intervention strategies, in particular against emerging, zoonotic and arboviral diseases, by offering customized in-vitro testing and in-vivo immunogenicity and efficacy testing capabilities Artemis Bioservices provides high quality preclinical and clinical services to developers of antiviral intervention strategies who want to evaluate the immunogenicity and efficacy of candidate products, especially against emerging, vector-borne and zoonotic viruses. Artemis Bioservices has recently been certified GLP compliant. Artemis Bioservices is located in the Yes!Delft Labs building, at Molengraaffsingel 10, 2629 JD, Delft, The Netherlands.